Evaluation and Management of Cardiovascular Risk Factors in Inflammatory and Acquired Dysimmune Diseases (CARMIN)

Civil Hospices of Lyon

Status: Completed

Conditions: Inflammatory and Acquired Dysimmune Diseases

Treatments: Other: Data collection

Study type: Observational

Funder types: Other

Identifiers

NCT02835547

D50841

Details and patient eligibility

About

The hypothesis is that chronic inflammatory dysimmune state promotes the development of cardiovascular complications. The biological assumption is based on the fact that chronic inflammation promotes lesions of the vessel wall (endothelial alterations, calcification, atherosclerosis). The clinical aim is to allow to identify high-risk patients and to act in prevention.

The project CARMIN involves the assessment of cardiovascular risk factors, their management, and their influence on cardiovascular prognosis in patients with autoimmune diseases and immunodeficiencies acquired. It is based on the creation and monitoring of a cohort of patients with different types of dysimmune disorders: systemic lupus erythematosus, rheumatoid arthritis, psoriasis, scleroderma, systemic vasculitis ANCA, kidney transplants, and hematopoietic stem cells transplants.

Enrollment: 600 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients followed in the various services of medical specialties pole of the Edouard Herriot hospital
• The diagnosis of the pathology selected for this study based on a clear clinical and biological evaluation supported by criteria specific to each pathology and compatible with international standards.
• Date of diagnosis should not be less than 5 years (+/- 1 year), except for scleroderma patients where it has been extended to 10 years.
• For kidney transplant patients the investigators take into account only patients with a maximum of 2 years of dialysis before graft.

Exclusion criteria

• Diabetic patients
• HIV seropositive
• Patients with multiple pathologies

Trial design

600 participants in 6 patient groups

Systemic lupus erythematosus

Description:

Data collection of risk factors (collected retrospectively - 5 years) and cardiovascular events (collected prospectively - 2 years).

Treatment:

Other: Data collection

Rheumatoid arthritis

Description:

Data collection of risk factors (collected retrospectively - 5 years) and cardiovascular events (collected prospectively - 2 years).

Treatment:

Other: Data collection

Psoriasis

Description:

Data collection of risk factors (collected retrospectively - 5 years) and cardiovascular events (collected prospectively - 2 years).

Treatment:

Other: Data collection

Scleroderma

Description:

Data collection of risk factors (collected retrospectively - 5 years) and cardiovascular events (collected prospectively - 2 years).

Treatment:

Other: Data collection

Hematopoietic stem cells transplants

Description:

Data collection of risk factors (collected retrospectively - 5 years) and cardiovascular events (collected prospectively - 2 years).

Treatment:

Other: Data collection

Kidney transplants

Description:

Data collection of risk factors (collected retrospectively - 5 years) and cardiovascular events (collected prospectively - 2 years).

Treatment:

Other: Data collection